Literature DB >> 19912586

Long-term storage of peripheral blood stem cells frozen and stored with a conventional liquid nitrogen technique compared with cells frozen and stored in a mechanical freezer.

Jeffrey McCullough1, Rebecca Haley, Mary Clay, Allison Hubel, Bruce Lindgren, Gary Moroff.   

Abstract

BACKGROUND: Cryopreservation of hematopoietic progenitor cells using liquid nitrogen and controlled-rate freezing requires complex equipment and highly trained staff and is expensive. We compared the liquid nitrogen method with methods using a combination of dimethyl sulfoxide (DMSO) and hydroxyethyl starch (HES) for cryopreservation followed by storage in mechanical freezers. STUDY DESIGN AND METHODS: Peripheral blood stem cells (PBSCs) were collected from normal donors by apheresis and allocated to one of four preservation and storage conditions: 1) 10% DMSO with freezing in liquid nitrogen and storage in liquid nitrogen, 2) 5% DMSO and 6% HES with freezing and storage in a -80 degrees C mechanical freezer, 3) 5% DMSO and 6% HES with freezing in a -80 degrees C mechanical freezer and storage in a -135 degrees C mechanical freezer, or 4) 5% DMSO and 6% HES with freezing and storage both in a 135 degrees C mechanical freezer. Cells were stored for 5 years during which total nucleated cells (TNCs), cell viability, CD34+ cell content, and colony-forming unit-granulocyte-macrophage content were determined.
RESULTS: There were some significant differences in the variables measured during freezing and the 5 years of storage compared to the values before freezing and storage; however, these differences were not consistent and do not favor one protocol over the others. Samples stored for 24 hours before cryopreservation showed a significant decrease in TNCs, but no other significant changes during the 5 years.
CONCLUSION: In vitro measurements indicate that PBSCs can be successfully frozen and stored using a combination of DMSO and HES providing smaller amounts of DMSO and allowing simplified freezing and storage conditions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19912586     DOI: 10.1111/j.1537-2995.2009.02482.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  15 in total

1.  Cryopreservation of Human Stem Cells for Clinical Application: A Review.

Authors:  Charles J Hunt
Journal:  Transfus Med Hemother       Date:  2011-03-16       Impact factor: 3.747

2.  Preserved in vivo reconstitution ability of PBSCs cryopreserved for a decade at -80 °C.

Authors:  T Shima; H Iwasaki; T Yamauchi; M Kadowaki; M Kiyosuke; T Mochimaru; K Takenaka; T Miyamoto; K Akashi; T Teshima
Journal:  Bone Marrow Transplant       Date:  2015-06-22       Impact factor: 5.483

3.  High-Throughput Processing to Preserve Viable Cells: A Precision Medicine Initiative Cohort Program Workshop.

Authors:  Rebekah S Rasooly; Daniel R Gossett; Marianne K Henderson; Allison Hubel; Stephen N Thibodeau
Journal:  Biopreserv Biobank       Date:  2017-04-25       Impact factor: 2.300

4.  Analysis of the recovery of cryopreserved and thawed CD34+ and CD3+ cells collected for hematopoietic transplantation.

Authors:  Virginia Fisher; Hanh Khuu; Virginia David-Ocampo; Karen Byrne; Steven Pavletic; Michael Bishop; Daniel H Fowler; A John Barrett; David F Stroncek
Journal:  Transfusion       Date:  2013-10-10       Impact factor: 3.157

5.  Long-term, large scale cryopreservation of insect cells at -80 °C.

Authors:  Lucie Vyletova; La'Verne P Rennalls; Kirstin J L Wood; Valerie M Good
Journal:  Cytotechnology       Date:  2014-08-23       Impact factor: 2.058

6.  Impact of uncontrolled freezing and long-term storage of peripheral blood stem cells at - 80 °C on haematopoietic recovery after autologous transplantation. Report from two centres.

Authors:  G Detry; L Calvet; N Straetmans; A Cabrespine; C Ravoet; J O Bay; H Petre; C Paillard; B Husson; E Merlin; L Boon-Falleur; O Tournilhac; A Delannoy; P Halle
Journal:  Bone Marrow Transplant       Date:  2014-03-31       Impact factor: 5.483

7.  Essential requirements for setting up a stem cell processing laboratory.

Authors:  T Leemhuis; D Padley; C Keever-Taylor; D Niederwieser; T Teshima; F Lanza; C Chabannon; P Szabolcs; A Bazarbachi; M B C Koh
Journal:  Bone Marrow Transplant       Date:  2014-06-16       Impact factor: 5.483

8.  How old is too old? In vivo engraftment of human peripheral blood stem cells cryopreserved for up to 18 years - implications for clinical transplantation and stability programs.

Authors:  John Underwood; Mahvish Rahim; Carijo West; Rebecca Britton; Elaine Skipworth; Vicki Graves; Steven Sexton; Hillary Harris; Dave Schwering; Anthony Sinn; Karen E Pollok; Kent A Robertson; W Scott Goebel; Kerry M Hege
Journal:  World J Stem Cells       Date:  2020-05-26       Impact factor: 5.326

9.  Evaluation of distinct freezing methods and cryoprotectants for human amniotic fluid stem cells cryopreservation.

Authors:  Felipe de Lara Janz; Adriana de Aguiar Debes; Rita de Cássia Cavaglieri; Sérgio Aloísio Duarte; Carolina Martinez Romão; Antonio Fernandes Morón; Marcelo Zugaib; Sérgio Paulo Bydlowski
Journal:  J Biomed Biotechnol       Date:  2012-05-14

10.  Effects of cryopreservation on the cell viability, proliferative capacity and neuronal differentiation potential of canine bone marrow stromal cells.

Authors:  Kazuya Edamura; Rei Nakano; Kyohei Fujimoto; Kenji Teshima; Kazushi Asano; Shigeo Tanaka
Journal:  J Vet Med Sci       Date:  2013-12-13       Impact factor: 1.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.